[Skip to Content]
[Skip to Content Landing]
Article
July 1922

THE ELIMINATION OF ARSENIC IN THE URINE OF SYPHILITIC PATIENTS AFTER INTRAVENOUS INJECTION OF ARSPHENAMIN

Author Affiliations

PHILADELPHIA

From the Dermatological Research Institute, Philadelphia. (Investigations aided by funds accruing from the preparation of arsphenamin.)

Arch Intern Med (Chic). 1922;30(1):85-93. doi:10.1001/archinte.1922.00110070088006
Abstract

Although the literature on arsphenamin has become extremely voluminous, yet there are relatively few reports of work done on the important subject of arsenic elimination after intravenous injection of this drug in which the arsenic determinations have been made by modern, accurate methods. Moreover, the older literature from 1910 to 1913 deals mostly with the intramuscular and subcutaneous methods of administration which are no longer in vogue today. For this reason, it has been deemed advisable to reinvestigate this subject on a series of carefully controlled patients with the use of more recent and acceptable methods.

REVIEW OF THE LITERATURE  The literature up to 1913 has been thoroughly reviewed by Ullman.1 We have gone over this literature and after thorough analysis, have decided to omit from this discussion the work of those authors2 who used inadequate methods for the destruction of the organic matter of the urine or tissues or

References
1.
Ullmann, K.:  Elimination and Storage of Salvarsan After Injection Into the Human and Animal Body ,  Arch. f. Dermat. u. Syph. 13:114, 511, 1912.
2.
Abelin, J.:  Beginning and Duration of Elimination of Salvarsan in the Urine After Injection ,  Ehrlich's Abhandlungen über Salvarsan 2:45, 1911.
3.
Greven, K.:  The Beginning and Duration of Elimination of Arsenic in the Urine After Treatment with Salvarsan ,  Ehrlich's Abhandlungen über Salvarsan 1:56-58, 1911.
4.
Frenkel-Heiden and Navassart, E.:  Ueber das Schicksal des Salvarsans im menschlichen Körper ,  Ztschr. f. Exper. Path. u. Therap. 13:531, 1913.Crossref
5.
Wilcox, W. H., and Webster, J.:  The Toxicology of Salvarsan ,  Brit. M. J. 1:473, 1916.Crossref
6.
Webster, J.:  The Analyst 41:231, 1916.Crossref
7.
Lockemann, J.:  Vergleichende Untersuchungen über die Arsenausscheidung durch den menschlichen Harn nach Injektion verschiedener Arsenikalien ,  Biochem. Ztschr. 78:1, 1916.
8.
Bergmann, H.:  The Retention and Elimination of Arsenic After the Administration of Salvarsan in Serum and Aqueous Solutions ,  Biochem. Ztschr. 90:348, 1918.
9.
Data are given only for two days in which percentage eliminated is 24.9 per cent.
10.
Weiss, C., and Corson, A.:  Chemical Studies of the Blood and Urine of Syphilitic Patients Under Arsphenamin Treatment ,  Arch. Int. Med. , 1921 (in press).
11.
Hawk, P. B.:  Practical Physiological Chemistry . P. Blakiston's Son & Co., Philadelphia, 1918, pp. 476-478.
12.
Scott, W. W.:  Standard Methods of Chemical Analysis , D. Van Nostrand Co., New York, 1918, p. 30.
13.
Bang, I.:  Quantitative Determination of Arsenic in Urine, Farmaceutisk Revy ,  Schweiz. Apoth. Ztg. 55:393, 1917.
14.
Green, H. H.:  The Microtitration of Arsenic, Union of South Africa Dept. Agriculture, Fifth and Sixth Reports, 1916-1918, of the Director of Veterinary Research ,  Pretoria 5:541-550, 1918.
15.
Raiziss, G. W.: Gavron, J. L., and Blatt, A. C.: The Estimation of Minute Quantities of Arsenic in the Urine (to be published).
16.
Vierordt, H.:  Anatomische und physiologische und physikalische Daten und Tabellen zum Gebrauche für Mediziner , Ed. 3, 1906, Jena.
17.
Stitt, E. R.:  Practical Bacteriology , Philadelphia, P. Blakiston's Son & Co., 1918, p. 540.
18.
Obregia, A., and Carniol, A.:  Sur l'elimination du neosalvarsan par la bile ,  Compt. rend. de la Soc. de biol. 78:468, 1915.
19.
Pomaret, M.:  L'elimination des Arsenobenzols ,  La méd. 2:123, 1920.
20.
Myers, C. N.:  Determination and Distribution of Arsenic in Certain Body Fluids After the Injection of Arsenobenzol, Salvarsan and Neo-Salvarsan , U. S. Public Health Rep., Reprint No. 520, 1919 (May 2) pp. 881-890.
21.
Barbat, J. H.:  Permeability of the Meninges to Arsenic in Paresis and Tabes ,  J. A. M. A. 70:147 ( (Jan. 19) ) 1918.Crossref
22.
Young, W. J.:  Fixation of Salvarsan and Neo-Salvarsan by the Blood After Intravenous Injection ,  Biochem. Jour. 9:479, 1915.
23.
Bailey, C. V., and MacKay, A.:  Toxic Jaundice in Patients Under Antisyphilitic Treatment ,  Arch. Int. Med. 25:628 ( (Nov.) ) 1920.Crossref
×